Skye Bioscience, Inc.

SKYE · XNAS

CIK 1516551fmd_11HGJVBXZW4PMA8YW9HJZ0NRSHManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Nov 01, 2011 to Sep 30, 2026, 62 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).